ARCHIVES

Why Four? NCI Official Challenged To Explain Rational For Proposed Number Of Groups

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | March 25, 2011

Download PDF Visit The Full Archive

Related Articles

In Brief: Bertino Moves To MSK As Head Of Chemotherapy Research; Rosemary Clive Laves ACOS For Elm

January 2, 1987

NRSAs Renamed For Kirschstein.

June 21, 2002

Genentech Reps Not Welcome: Hospitals Urge Drug Maker to Reverse Policy On Supplying Avastin, Rituxan, & Herceptin

October 17, 2014

ASCO Issues RFP To Establish Washington Office

August 11, 1989

NSABP Investigator Recounts Loyalty To Fisher, “Betrayal”

June 3, 1994

To Improve Clinical Trials Participation, Groups Plan An Awareness Campaign.

October 13, 2000